Abstract Background Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving chronic dialysis therapy. Although cinacalcet can control parathyroid function and bone turnover, preventing ectopic calcification remains challenging. Cinacalcet can also suppress PTH secretion due to parathyroid carcinoma in the same way as it does for parathyroid hyperplasia in the uremic condition. We present a case of parathyroid carcinoma partially controlled by cinacalcet, in which tumorous calcinosis was successfully resolved by total parathyroidectomy. Case presentation A female patient in her forties who had received dialysis for 12 years was referred to our hospital for painful ectopic calcifications on her right hip joint and ...
Background: Secondary hyperparathyroidism a common consequence of chronic kidney disease is associat...
Copyright © 2014 D. Grove-Laugesen and L. Rejnmark. This is an open access article distributed under...
BACKGROUND: Secondary hyperparathyroidism (SHPT) in chronic kidney disease is associated with cardio...
Abstract • Introduction In the treatment of secondary hyperparathyroidism (2HPT) of chronic kidney...
Abstract Introduction In the treatment of secondary hyperparathyroidism of chronic kidney disease, c...
Cinacalcet HCl: A novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney diseas...
The incidence of the secondary hyperparathyroidism (HPT) after parathyroidectomy (PTE) in dialysis p...
The effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary hyperparathyroidi...
Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism.Ba...
Introduction — Secondary hyperparathyroidism (SHPT) is common in patients with chronic kidney diseas...
AbstractBackgroundThe effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary...
Cinacalcet is a type II calcimimetic agent which is an allosteric modulator of the calcium-sensing r...
A 77-year-old man was referred to our department for surgical treatment of a right ureteral stone id...
BACKGROUND: The calcimimetic agent cinacalcet is effective for the management of secondary hyperpara...
Background: Secondary hyperparathyroidism (SHPT) is one of the common complications in dialysis pati...
Background: Secondary hyperparathyroidism a common consequence of chronic kidney disease is associat...
Copyright © 2014 D. Grove-Laugesen and L. Rejnmark. This is an open access article distributed under...
BACKGROUND: Secondary hyperparathyroidism (SHPT) in chronic kidney disease is associated with cardio...
Abstract • Introduction In the treatment of secondary hyperparathyroidism (2HPT) of chronic kidney...
Abstract Introduction In the treatment of secondary hyperparathyroidism of chronic kidney disease, c...
Cinacalcet HCl: A novel treatment for secondary hyperparathyroidism in stage 5 chronic kidney diseas...
The incidence of the secondary hyperparathyroidism (HPT) after parathyroidectomy (PTE) in dialysis p...
The effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary hyperparathyroidi...
Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism.Ba...
Introduction — Secondary hyperparathyroidism (SHPT) is common in patients with chronic kidney diseas...
AbstractBackgroundThe effects of cinacalcet in persistent and/or hypercalcaemia-associated secondary...
Cinacalcet is a type II calcimimetic agent which is an allosteric modulator of the calcium-sensing r...
A 77-year-old man was referred to our department for surgical treatment of a right ureteral stone id...
BACKGROUND: The calcimimetic agent cinacalcet is effective for the management of secondary hyperpara...
Background: Secondary hyperparathyroidism (SHPT) is one of the common complications in dialysis pati...
Background: Secondary hyperparathyroidism a common consequence of chronic kidney disease is associat...
Copyright © 2014 D. Grove-Laugesen and L. Rejnmark. This is an open access article distributed under...
BACKGROUND: Secondary hyperparathyroidism (SHPT) in chronic kidney disease is associated with cardio...